Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Graves Disease

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Graves Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogrin, C1

Other Studies

1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Graves Disease

ArticleYear
Increased bone alkaline phosphatase and isolated subcortical bone uptake of technetium-99m hydroxymethylene diphosphonate in the lower extremities in a patient with Graves' disease: a distinctly unusual variant of Graves' acropachy.
    Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:11

    Topics: Alkaline Phosphatase; Bone and Bones; Female; Femur; Graves Disease; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tibia

2008